Count | |
| 2 | |
| 1 | |
alpha-Linolenic Acid/administration & dosage/blood/*pharmacology | 1 |
| 3 | |
| 3 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 3 | |
| 1 | |
| 8 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
gamma-Linolenic Acid/*administration & dosage/adverse effects | 1 |
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 16 |
| 1 | |
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/metabolism | 1 |
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/*pharmacology | 1 |
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/*metabolism | 2 |
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/pharmacology | 4 |
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/toxicity | 1 |
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/*antagonists & | 1 |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 3 | |
| 2 | |
| 2 | |
| 2 | |
| 1 | |
| 3 | |
| 1 | |
| 2 | |
| 23 | |
| 9 | |
| 3 | |
| 5 | |
| 5 | |
| 3 | |
| 1 | |
| 1 | |
| 2 | |
| 11 | |
| 10 | |
| 4 | |
| 18 | |
| 8 | |
| 4 | |
| 3 | |
| 1 | |
| 9 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 6 | |
| 1 | |
| 1 | |